These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 4547286)

  • 1. Properties of post-infusion factor VIII in von Willebrand's disease.
    Muntz RH; Ekert H; Helliger H
    Thromb Res; 1974 Aug; 5(2):111-23. PubMed ID: 4547286
    [No Abstract]   [Full Text] [Related]  

  • 2. Factor VIII (Willebrand) antigen and ristocetin-Willebrand factor in pigs with von Willebrand's disease.
    Fass DN; Brockway WJ; Owen CA; Bowie EJ
    Thromb Res; 1976 Mar; 8(3):319-27. PubMed ID: 1083569
    [No Abstract]   [Full Text] [Related]  

  • 3. Dissociation between factor VIII (activity and antigen) and ristocetin-induced platelet aggregation in von Willebrand's disease.
    Barbui T; Dini E
    Acta Haematol; 1975; 53(1):44-8. PubMed ID: 807074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired von Willebrand syndrome with inhibitors both to factor VIII clotting activity and ristocetin-induced platelet aggregation.
    Stableforth P; Tamagnini GL; Dormandy KM
    Br J Haematol; 1976 Aug; 33(4):565-73. PubMed ID: 1087568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter: Willebrand-factor activity and antigen in von Willebrand's disease.
    Meyer D; Jenkins CS; Dreyfus M; Larieu MJ
    Lancet; 1974 Mar; 1(7856):512-3. PubMed ID: 4131919
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemophilia and von Willebrand's disease. Some biological determinants. H. P. Smith memorial lecture.
    Brinkhous KM
    Am J Clin Pathol; 1975 May; 63(5):609-17. PubMed ID: 1093384
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of an inhibitor specific to factor VIII: coagulant activity in a patient with platelet-type von Willebrand's disease.
    Castella A; Miller JL; Neuberg RW; Gawryl MS; Hoyer LW
    Am J Clin Pathol; 1983 Nov; 80(5):745-9. PubMed ID: 6416054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The von Willebrand syndrome.
    Stableforth P; Hughes J; Wilson E; Dormandy KM
    Br J Haematol; 1975 Apr; 29(4):605-16. PubMed ID: 1081404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Von Willebrand's syndrome. Studies on a variant factor VIII.
    Hill FG; Chan MC; Hardisty RM
    Haemostasis; 1976; 5(5):276-84. PubMed ID: 797643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of von Willebrand's disease. A comparative study of diagnostic tests on nine families with von Willebrand's disease and its differential diagnosis from hemophilia and thrombocytopathy.
    Lian EC; Deykin D
    Am J Med; 1976 Mar; 60(3):344-56. PubMed ID: 1083143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Von Willebrand's disease.
    Zimmerman TS; Ruggeri ZM
    Prog Hemost Thromb; 1982; 6():203-36. PubMed ID: 6820163
    [No Abstract]   [Full Text] [Related]  

  • 13. Failure of AHF concentration to control bleeding in von Willebrand's disease.
    Green D; Potter EV
    Am J Med; 1976 Mar; 60(3):357-60. PubMed ID: 1083144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Von Willebrand's disease (author's transl)].
    Jacky E; Blättler W; Müller M
    Ther Umsch; 1979 Apr; 36(4):341-4. PubMed ID: 377558
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: Factor VIII in von Willebrand's disease.
    Holmberg L; Nilsson IM; Rasovic N
    Lancet; 1974 Oct; 2(7887):1027. PubMed ID: 4138305
    [No Abstract]   [Full Text] [Related]  

  • 16. Transfusion and gel filtration studies in von Willebrand's disease.
    Kernoff PB; Rizza CR; Kaelin AC
    Br J Haematol; 1974 Nov; 28(3):357-70. PubMed ID: 4548357
    [No Abstract]   [Full Text] [Related]  

  • 17. Factor VIII in von Willebrand' disease.
    Irwin JF
    Semin Thromb Hemost; 1975 Oct; 2(2):85-104. PubMed ID: 798271
    [No Abstract]   [Full Text] [Related]  

  • 18. Infusion of human and canine factor VIII in dogs with von Willebrand's disease: studies of the von Willebrand and factor VIII synthesis stimulating factors.
    Bouma BN; Dodds WJ; van Mourik JA; Sixma JJ; Webster WP
    Scand J Haematol; 1976 Oct; 17(4):263-75. PubMed ID: 825957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [von Willebrand's disease with an increased ristocetin-induced platelet aggregation and a qualitative abnormality of the factor VIII protein (author's transl)].
    Takahashi H; Oda E; Hattori A; Kobayashi I; Takahashi K; Sakuragawa N; Shibata A
    Rinsho Ketsueki; 1980 Apr; 21(4):544-54. PubMed ID: 6774131
    [No Abstract]   [Full Text] [Related]  

  • 20. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
    Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
    N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.